Progenus Overview

  • Founded
  • 2001
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

Progenus General Information


Provider of research and laboratory services intended to test animal genetics. The company's departments develops and sells its own analysis kits, provides services like DNA analysis, and helps in research & development of a simple test to a complete project, thereby enabling businesses to perform tests on animals, plants and microorganisms.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • Crealys Scientific Park
  • Rue Camille Hubert, 7A
  • 5032 Gembloux
  • Belgium
+32 081 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Progenus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jun-2012 Completed Generating Revenue
To view Progenus’s complete valuation and funding history, request access »

Progenus Executive Team (3)

Name Title Board Seat Contact Info
Robert Renaville Ph.D Founder & Chief Executive Officer
Renaville Benedicte Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Progenus Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Progenus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Namur Invest Venture Capital Minority 000 0000 000000 0
To view Progenus’s complete investors history, request access »